Biotech | October 29, 2021
NH TherAguix releases new batch for AGuIX
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
Acute therapies continue to report strong growth compared to chronic ones.
The combined entity will have 12 hospitals with 3,666 beds
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Subscribe To Our Newsletter & Stay Updated
